Stocklytics Platform
Asset logo for symbol ELAN
Elanco Animal Health
ELAN44
$12.86arrow_drop_up1.46%$0.18
Asset logo for symbol ELAN
ELAN44

$12.86

arrow_drop_up1.46%

Performance History

Chart placeholder
Key Stats
Open$12.82
Prev. Close$12.67
EPS-2.54
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range12.65
13.07
52 Week Range8.52
18.80
Ratios
EPS-2.54

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Elanco Animal Health (ELAN)

The Elanco Animal Health Inc (ELAN) is a global company that focuses on the development and commercialization of products for animal health. The company offers a wide range of products including medicines, vaccines, and feed additives for both companion animals and livestock. With a history dating back over 60 years, Elanco has established itself as a leader in the animal health industry. The company's mission is to improve the health and well-being of animals, while also benefiting the farmers, pet owners, and veterinarians who care for them. Elanco operates in more than 90 countries and has a diverse portfolio of products that serve a variety of species, including dogs, cats, cattle, swine, and poultry.
Elanco Animal Health Inc, with its strong market presence and innovative product offerings, has experienced significant growth in recent years. The company's stock price history reflects this success, with steady increases in value over time. Investors have been drawn to Elanco's potential for long-term growth in the animal health sector, which is expected to continue expanding as the global population increases and demand for protein products rises. ELAN stock is traded on the New York Stock Exchange and has consistently outperformed the broader market. The stock's performance is closely tied to the company's financial results, which have shown consistent revenue and earnings growth. Elanco's market cap has also increased significantly in recent years, reflecting investor confidence in the company's future prospects.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Jeffrey N. Simmons
Headquarters
Greenfield
Employees
9000
Exchange
NYSE
add Elanco Animal Health  to watchlist

Keep an eye on Elanco Animal Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Elanco Animal Health 's (ELAN) price per share?

The current price per share for Elanco Animal Health (ELAN) is $12.86. The stock has seen a price change of $0.19 recently, indicating a 1.46% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Elanco Animal Health (ELAN)?

For Elanco Animal Health (ELAN), the 52-week high is $18.8, which is 46.19% from the current price. The 52-week low is $8.52, the current price is 50.94% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Elanco Animal Health (ELAN) a growth stock?

Elanco Animal Health (ELAN) has shown an average price growth of -1.92% over the past three years. It has received a score of 26 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Elanco Animal Health as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Elanco Animal Health (ELAN) stock price performance year to date (YTD)?

As of the latest data, Elanco Animal Health (ELAN) has a year-to-date price change of -12.16%. Over the past month, the stock has experienced a price change of -11.62%. Over the last three months, the change has been 8.52%. Over the past six months, the figure is -3.02%. Looking at a longer horizon, the five-year price change stands at -53.12%.
help

Is Elanco Animal Health (ELAN) a profitable company?

Elanco Animal Health (ELAN) has a net income of -$1.23B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.28% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 9.71% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $4.42B, although specific revenue growth data is currently not available. The gross profit is $2.49B. Operating income is noted at $326M. Furthermore, the EBITDA is $918M.
help

What is the market capitalization of Elanco Animal Health (ELAN)?

Elanco Animal Health (ELAN) has a market capitalization of $6.36B. The average daily trading volume is 12.83, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level